<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-20509" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Diffuse Intrinsic Pontine Glioma</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Pellot</surname>
            <given-names>Joel E.</given-names>
          </name>
          <aff>University of Puerto Rico</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>De Jesus</surname>
            <given-names>Orlando</given-names>
          </name>
          <aff>University of Puerto Rico, Medical Sciences Campus, Neurosurgery Section</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Joel Pellot declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Orlando De Jesus declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>23</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-20509.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Diffuse intrinsic pontine glioma (DIPG) is an aggressive type of childhood cancer that forms in the brainstem. They are very rare and almost always occur in the pediatric population. To avoid the high morbidity and mortality associated with this condition, DPIG must be promptly diagnosed and treated. This activity reviews the evaluation and treatment of diffuse intrinsic pontine gliomas and highlights the role of the interprofessional team in the care of patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of diffuse intrinsic pontine glioma.</p></list-item><list-item><p>Review the appropriate process for the evaluation of diffuse intrinsic pontine glioma.</p></list-item><list-item><p>Outline the management options available for diffuse intrinsic pontine glioma.</p></list-item><list-item><p>Summarize interprofessional team strategies for improving care coordination and communication to advance the care of diffuse intrinsic pontine glioma and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20509&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20509">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-20509.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Diffuse intrinsic pontine glioma (DIPG) is an aggressive tumor of the brainstem. It almost always affects the pediatric population, with approximately 200&#x000a0;to 300 new annual cases in the United States. Most patients survive less than one year.<xref ref-type="bibr" rid="article-20509.r1">[1]</xref>&#x000a0;These patients were primarily treated with radiation therapy, as surgical resection was not a viable option for them. The effects of radiation therapy are temporary, and no chemotherapeutic agent has been effective in treating this pathology. Several clinical trials of new agents and novel therapeutic approaches have emerged over the past decades to improve the outcome of patients with DIPGs, yet no success has been obtained.</p>
      </sec>
      <sec id="article-20509.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The formation of this tumor may be linked to brain development. Studies suggest that the disease process is created by particular cells that exist in very high concentrations, while the cerebral tissue is developing. This theory is supported by the fact that this tumor rarely occurs in adults and almost always occurs in mid-childhood (ages 5&#x000a0;to 10), a period in which the cerebral tissue is very active in development. The model has identified the neural precursor-like cell population in the normal human ventral pons that is linked both anatomically and temporally to the incidence of DIPG.<xref ref-type="bibr" rid="article-20509.r2">[2]</xref><xref ref-type="bibr" rid="article-20509.r3">[3]</xref>&#x000a0;The frequency of this cell type during mid-childhood mirrors the bell-shaped incidence curve of DIPG. These cells are notably absent in the midbrain, where DIPGs are virtually nonexistent.<xref ref-type="bibr" rid="article-20509.r1">[1]</xref><xref ref-type="bibr" rid="article-20509.r4">[4]</xref></p>
        <p>On the molecular level, recent advances in the biological understanding of the disease have identified the H3K27M mutation in nearly 80% of DIPGs, leading to the 2016 World Health Organization (WHO) classification of diffuse midline glioma H3K27M-mutant, a grade IV brainstem tumor.<xref ref-type="bibr" rid="article-20509.r5">[5]</xref></p>
      </sec>
      <sec id="article-20509.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Brainstem gliomas affect approximately 300 children in the United States each year and are the major cause of death in children with brain tumors. The most common of these is DIPG comprising 80% of the cases. Incidence is 1&#x000a0;to 2 cases per 100,000 population. DIPG has a peak incidence of 6-9 years and a slight preference for males.<xref ref-type="bibr" rid="article-20509.r6">[6]</xref>&#x000a0;Among all the tumors in children, they represent 20% of them.</p>
      </sec>
      <sec id="article-20509.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>One of the most accepted theories for the development of DIPG is a mutation in the H3 gene. Mutations in the N-terminal tail of histone H3 gene have been recently found in midline pontine high-grade gliomas and at a high frequency in DIPG. Substitution of the lysine at position 27 of the H3 encoding gene is the driving force behind DIPG oncogenesis.<xref ref-type="bibr" rid="article-20509.r7">[7]</xref>&#x000a0;It is implied that whichever histone H3 variant is targeted by the mutation (H3.1, H3.2, or H3.3), may lead to the development of a DIPG. The H3K27 mutation and loss of H3K27me3 are of paramount importance since it is characteristic of DIPG and likely represents the first genomic event leading to transformation in these tumors. DIPG thus appears as a homogeneous tumor group defined as a glial neoplasm with a stereotypical epigenetic drive consecutive to the histone H3 mutation. All H3K27 mutations described in DIPG appear to have the same epigenomic consequences on the&#x000a0;polycomb repressive&#x000a0;complex&#x000a0;2 despite the distinct functions and genomic distribution of the different variants.<xref ref-type="bibr" rid="article-20509.r8">[8]</xref></p>
      </sec>
      <sec id="article-20509.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>DIPG belongs to the fibrillary astrocytoma family. Most lesions are WHO grade III or IV.<xref ref-type="bibr" rid="article-20509.r1">[1]</xref><xref ref-type="bibr" rid="article-20509.r9">[9]</xref>&#x000a0;Very few cases are WHO grade II, but they&#x000a0;act similar to the high-grade cases.<xref ref-type="bibr" rid="article-20509.r10">[10]</xref>&#x000a0;The disparity between histological grade and clinical outcome may be overcome by using molecular features in the tumoral cells.<xref ref-type="bibr" rid="article-20509.r11">[11]</xref></p>
        <p>Microscopically, DIPG infiltrates grey and white matter structures. The tumor cells are generally small and monomorphic, but sometimes can be large and pleomorphic. They typically have an astrocytic morphology, although oligodendroglial morphology is also a recognized pattern. The majority of the tumors have mitotic figures, microvascular proliferation, and necrosis. About 10% of DIPGs lack mitotic figures and microvascular proliferation; thus, they are histologically consistent with WHO grade II.</p>
      </sec>
      <sec id="article-20509.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The clinical course for children with DIPG is rapid.<xref ref-type="bibr" rid="article-20509.r4">[4]</xref>&#x000a0;Most symptoms start less than four weeks before seeking medical attention. Symptoms are caused by dysfunction of pontine structures, including long tracts and cranial nerve nuclei. Diplopia is usually the first sign secondary to&#x000a0;abducens nerve palsy. Damage to the facial nucleus will produce facial weakness or paralysis. Damage to the long motor tracts will produce weakness and hyperreflexia. Dysfunction of the cerebellopontine connections will cause&#x000a0;ataxia, dysmetria, dysarthria. A classic triad in DIPG is present in about 50% of the patients, which includes&#x000a0;long tract signs, cerebellar signs, and cranial nerve neuropathies.<xref ref-type="bibr" rid="article-20509.r1">[1]</xref><xref ref-type="bibr" rid="article-20509.r4">[4]</xref>&#x000a0;Hydrocephalus occurs in less than 10% of the cases, but if untreated, it can progress to coma and death.<xref ref-type="bibr" rid="article-20509.r12">[12]</xref></p>
      </sec>
      <sec id="article-20509.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Magnetic resonance imaging (MRI) of the brain with and without contrast is the best diagnostic study to evaluate a patient with suspected DIPG. Usually, more than half of the enlarged ventral pons will show an increased signal on the T2 FLAIR MRI sequence.&#x000a0;The tumor will not show contrast enhancement, but occasionally, small areas of necrosis can enhance. Higher values on the apparent diffuse coefficient derived from diffusion-weighted MRI images correlates with&#x000a0;better median survival.<xref ref-type="bibr" rid="article-20509.r13">[13]</xref><xref ref-type="bibr" rid="article-20509.r14">[14]</xref>&#x000a0;Brain MRI will assess leptomeningeal tumor dissemination. MRI of the entire spine is recommended to exclude spinal seeding.<xref ref-type="bibr" rid="article-20509.r15">[15]</xref> In patients without hydrocephalus, a lumbar puncture can be performed for&#x000a0;cerebrospinal fluid analysis to evaluate for tumoral cells and circulating tumoral DNA (ctDNA, detecting the H3K27 mutation).<xref ref-type="bibr" rid="article-20509.r16">[16]</xref><xref ref-type="bibr" rid="article-20509.r17">[17]</xref><xref ref-type="bibr" rid="article-20509.r18">[18]</xref></p>
      </sec>
      <sec id="article-20509.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Steroids, specifically dexamethasone, are given, and the goal of treatment is the stabilization of neurological symptoms until possible neurosurgical biopsy or radiation therapy. Complications due to long term use should be avoided; thus, it should be weaned off as quickly as tolerated.<xref ref-type="bibr" rid="article-20509.r19">[19]</xref><xref ref-type="bibr" rid="article-20509.r20">[20]</xref>&#x000a0;Steroids stabilize the blood-brain barrier and can affect tissue penetration of systemic therapies.<xref ref-type="bibr" rid="article-20509.r21">[21]</xref>&#x000a0;Additionally, dexamethasone use in high-grade gliomas is associated with worse overall survival.<xref ref-type="bibr" rid="article-20509.r22">[22]</xref>&#x000a0;During the management, less than 10% of patients diagnosed with DIPGs develop hydrocephalus and require a third ventriculostomy or ventricular shunt.<xref ref-type="bibr" rid="article-20509.r23">[23]</xref></p>
        <p>The most important step in management is obtaining a tissue diagnosis. First, it characterizes the lesion for classification and treatment, and second, it is used for research and development of more effective management strategies. Nevertheless, there has been a historical resistance to biopsy of these tumors, because of anatomical access. Fortunately, the technology has advanced, and stereotactic biopsy is a safe and minimally invasive procedure that has a very low complication rate. Based on the literature, a stereotactic biopsy of DIPG is as safe and diagnostic as a supratentorial biopsy, and the amount of tissue in the biopsy allows for analysis, including whole-genome sequencing.<xref ref-type="bibr" rid="article-20509.r17">[17]</xref><xref ref-type="bibr" rid="article-20509.r24">[24]</xref><xref ref-type="bibr" rid="article-20509.r25">[25]</xref><xref ref-type="bibr" rid="article-20509.r26">[26]</xref></p>
        <p>Radiation oncologists are consulted immediately after diagnosis to plan further treatment. Even though there have been tremendous advancements in radiation and research in oncology,&#x000a0;outcomes for survival&#x000a0;for children with DIPGs have not changed significantly over the past 20 years.<xref ref-type="bibr" rid="article-20509.r27">[27]</xref>&#x000a0;Conventionally fractionated radiotherapy is still the standard of care for children with DIPGs, but hypofractionated radiotherapy has shown promising results when compared with conventional radiotherapy.<xref ref-type="bibr" rid="article-20509.r27">[27]</xref>&#x000a0;Radiotherapy is usually given to the tumor for a total dose of 54 Gy for six weeks (1.8-Gy daily fractions). Hypofractionated radiation&#x000a0;with 39 Gy using fewer fractions have similar outcomes and is better tolerated in young children.<xref ref-type="bibr" rid="article-20509.r28">[28]</xref><xref ref-type="bibr" rid="article-20509.r29">[29]</xref>&#x000a0;Re-irradiation for tumor progression can be considered with 25 Gy given over ten fractions producing a mild symptom or survival benefit.<xref ref-type="bibr" rid="article-20509.r30">[30]</xref><xref ref-type="bibr" rid="article-20509.r31">[31]</xref>&#x000a0;Radiosensitizing agents do not improve survival.</p>
        <p>Several clinical trials of various systemic therapies, including stem cell transplantation,&#x000a0;temozolomide,&#x000a0;gemcitabine, capecitabine, and tyrosine kinase inhibitors have been tested or are ongoing. Still, none have proved to increase the survival of children with DIPGs.<xref ref-type="bibr" rid="article-20509.r15">[15]</xref><xref ref-type="bibr" rid="article-20509.r32">[32]</xref>&#x000a0;Convection-enhanced drug delivery systems have brought hope to the treatments of DIPGs. Improvements in this field may provide better drug delivery systems and target these tumor cells directly, especially at the normal brain tissue interface.<xref ref-type="bibr" rid="article-20509.r33">[33]</xref>&#x000a0;A new therapy for the management of DIPG is adjuvant multimodal immunotherapy. This therapy consists of&#x000a0;vaccination cycles (Newcastle disease virus, mature dendritic cells) and immunogenic cell death therapy (temozolomide, local modulated electro-hyperthermia), offering improved overall survival but warrants further investigation.<xref ref-type="bibr" rid="article-20509.r34">[34]</xref></p>
      </sec>
      <sec id="article-20509.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Midbrain gliomas</p>
          </list-item>
          <list-item>
            <p>Cervicomedullary glioma</p>
          </list-item>
          <list-item>
            <p>Pilocytic astrocytoma</p>
          </list-item>
          <list-item>
            <p>Cavernous malformation</p>
          </list-item>
          <list-item>
            <p>Demyelinating disease</p>
          </list-item>
          <list-item>
            <p>Infectious diseases</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20509.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of DPIG is dismal due to the absence of effective therapies. This tumor is the principal cause of death among brain tumors affecting childhood. Most patients are diagnosed before seven years of age. After diagnosis, median survival is usually nine months. Only 10% live for more than two years.<xref ref-type="bibr" rid="article-20509.r35">[35]</xref>&#x000a0;When compared to pediatric glioblastoma, the prognosis for DIPG is the worst with less overall survival.</p>
      </sec>
      <sec id="article-20509.s12" sec-type="Complications">
        <title>Complications</title>
        <list list-type="bullet">
          <list-item>
            <p>Facial paralysis</p>
          </list-item>
          <list-item>
            <p>Dysphagia</p>
          </list-item>
          <list-item>
            <p>Respiratory insufficiency</p>
          </list-item>
          <list-item>
            <p>Hemiparesis</p>
          </list-item>
          <list-item>
            <p>Deep vein thrombosis</p>
          </list-item>
          <list-item>
            <p>Hydrocephalus</p>
          </list-item>
          <list-item>
            <p>Radiation necrosis</p>
          </list-item>
          <list-item>
            <p>Brain herniation</p>
          </list-item>
          <list-item>
            <p>Coma</p>
          </list-item>
          <list-item>
            <p>Surgical complications (intracranial hemorrhage, edema, seizures, and cranial nerve injury)</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20509.s13" sec-type="Consultations">
        <title>Consultations</title>
        <list list-type="bullet">
          <list-item>
            <p>Neuro oncologist</p>
          </list-item>
          <list-item>
            <p>Radiation oncologist</p>
          </list-item>
          <list-item>
            <p>Neuroradiologist</p>
          </list-item>
          <list-item>
            <p>Neurosurgeon</p>
          </list-item>
          <list-item>
            <p>Neurologist</p>
          </list-item>
          <list-item>
            <p>Neuropathologist</p>
          </list-item>
          <list-item>
            <p>Pediatric intensivist</p>
          </list-item>
        </list>
        <p>An early consideration should be the consultation of advanced pediatric care or pediatric palliative care specialists. Offering palliative care services to all patients with DIPG early in the course of the disease provides support for the immediate and ongoing physical, psychological, and social effects this lethal disease will have on the patient and the family. Combined neuro-oncologic and palliative care support maximize how patients and families&#x000a0;perform during their treatment and can even help to identify disease-related changes before clinically or radiographically suspected progression.<xref ref-type="bibr" rid="article-20509.r36">[36]</xref></p>
      </sec>
      <sec id="article-20509.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients with DIPG and family members should have a complete understanding of the disease and prognosis to have realistic expectations. The timeline of how early the patient is diagnosed will have an important part in how the family reacts to the situation. It is why, in the early phase, psychologists, psychiatrists, and family therapists should form part of the team.&#x000a0;The realities of deficits, physical impediments, and overall conditions after treatments should be clearly explained to the parents. Thorough training of how to manage these situations is necessary, including nasogastric nutrition, foley catheter, the possibility of being bedridden, and sacral ulcers.</p>
      </sec>
      <sec id="article-20509.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>While the pediatrician is almost always involved in the care of a patient with DIPG, it is essential to consult with an interprofessional team of specialists that include a neurosurgeon, neuro-oncologist, and radiation oncologist. The nurses are also vital members of the interprofessional group as they will monitor the patient's vital signs and assist with the education of the patient and the family. In the perioperative period for pain, wound infection, and nausea/vomit, the pharmacist will ensure that the patient is on the right analgesics, antiemetics, and appropriate antibiotics. The problem gets even more complicated when the parents suffer the emotional burden of the dismal prognosis of&#x000a0;DIPG. Early phase interaction with psychologists, psychiatrists, and family therapists are needed to handle this critical issue.</p>
      </sec>
      <sec id="article-20509.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20509&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20509">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/cancer/diffuse-intrinsic-pontine-glioma/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=20509">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/20509/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=20509">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-20509.s17">
        <fig id="article-20509.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Typical MRI appearance of diffuse intrinsic pontine glioma (DIPG). (A) T1-weighted post contrast, (B) T2-weighted, (C) FLAIR. Contributed from Warren KE (2012) Diffuse intrinsic pontine glioma: poised for progress. Front. Oncol. 2:205. doi:10.3389/fonc.2012.00205 (CC BY 3.0 https://creativecommons.org/licenses/by/3.0/deed.en)</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="800px-Typical_MRI_appearance_of_diffuse_intrinsic_pontine_glioma_xDIPGx_-_Fonc-02-00205-g002" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-20509.s18">
        <title>References</title>
        <ref id="article-20509.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fisher</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Breiter</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Carson</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Wharam</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Weingart</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Foer</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Goldthwaite</surname>
                <given-names>PT</given-names>
              </name>
              <name>
                <surname>Tihan</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Burger</surname>
                <given-names>PC</given-names>
              </name>
            </person-group>
            <article-title>A clinicopathologic reappraisal of brain stem tumor classification. Identification of pilocystic astrocytoma and fibrillary astrocytoma as distinct entities.</article-title>
            <source>Cancer</source>
            <year>2000</year>
            <month>Oct</month>
            <day>01</day>
            <volume>89</volume>
            <issue>7</issue>
            <fpage>1569</fpage>
            <page-range>1569-76</page-range>
            <pub-id pub-id-type="pmid">11013373</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20509.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shors</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Miesegaes</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Beylin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rydel</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Gould</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Neurogenesis in the adult is involved in the formation of trace memories.</article-title>
            <source>Nature</source>
            <year>2001</year>
            <month>Mar</month>
            <day>15</day>
            <volume>410</volume>
            <issue>6826</issue>
            <fpage>372</fpage>
            <page-range>372-6</page-range>
            <pub-id pub-id-type="pmid">11268214</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20509.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weiss</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dunne</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hewson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wohl</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wheatley</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Peterson</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Reynolds</surname>
                <given-names>BA</given-names>
              </name>
            </person-group>
            <article-title>Multipotent CNS stem cells are present in the adult mammalian spinal cord and ventricular neuroaxis.</article-title>
            <source>J Neurosci</source>
            <year>1996</year>
            <month>Dec</month>
            <day>01</day>
            <volume>16</volume>
            <issue>23</issue>
            <fpage>7599</fpage>
            <page-range>7599-609</page-range>
            <pub-id pub-id-type="pmid">8922416</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20509.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Donaldson</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Laningham</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Fisher</surname>
                <given-names>PG</given-names>
              </name>
            </person-group>
            <article-title>Advances toward an understanding of brainstem gliomas.</article-title>
            <source>J Clin Oncol</source>
            <year>2006</year>
            <month>Mar</month>
            <day>10</day>
            <volume>24</volume>
            <issue>8</issue>
            <fpage>1266</fpage>
            <page-range>1266-72</page-range>
            <pub-id pub-id-type="pmid">16525181</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20509.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Williams</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Vitanza</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>McGrath</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Feroze</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Browd</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Hauptman</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Progress in diffuse intrinsic pontine glioma: advocating for stereotactic biopsy in the standard of care.</article-title>
            <source>Neurosurg Focus</source>
            <year>2020</year>
            <month>Jan</month>
            <day>01</day>
            <volume>48</volume>
            <issue>1</issue>
            <fpage>E4</fpage>
            <pub-id pub-id-type="pmid">31896081</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20509.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Barrett</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Dai</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Qin</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Identification of new therapeutic targets and natural compounds against diffuse intrinsic pontine glioma (DIPG).</article-title>
            <source>Bioorg Chem</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>99</volume>
            <fpage>103847</fpage>
            <pub-id pub-id-type="pmid">32311581</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20509.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Castel</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Philippe</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Calmon</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Le Dret</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Truffaux</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Boddaert</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Pag&#x000e8;s</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Saulnier</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lacroix</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mackay</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sainte-Rose</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Blauwblomme</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Andreiuolo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Puget</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Grill</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Varlet</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Debily</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes.</article-title>
            <source>Acta Neuropathol</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>130</volume>
            <issue>6</issue>
            <fpage>815</fpage>
            <page-range>815-27</page-range>
            <pub-id pub-id-type="pmid">26399631</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20509.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chan</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Fang</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gan</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hashizume</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Schroeder</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mueller</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>James</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Jenkins</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sarkaria</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression.</article-title>
            <source>Genes Dev</source>
            <year>2013</year>
            <month>May</month>
            <day>01</day>
            <volume>27</volume>
            <issue>9</issue>
            <fpage>985</fpage>
            <page-range>985-90</page-range>
            <pub-id pub-id-type="pmid">23603901</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20509.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yoshimura</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Onda</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tanaka</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Clinicopathological study of diffuse type brainstem gliomas: analysis of 40 autopsy cases.</article-title>
            <source>Neurol Med Chir (Tokyo)</source>
            <year>2003</year>
            <month>Aug</month>
            <volume>43</volume>
            <issue>8</issue>
            <fpage>375</fpage>
            <page-range>375-82; discussion 382</page-range>
            <pub-id pub-id-type="pmid">12968803</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20509.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Buczkowicz</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bartels</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Bouffet</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Becher</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Hawkins</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications.</article-title>
            <source>Acta Neuropathol</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>128</volume>
            <issue>4</issue>
            <fpage>573</fpage>
            <page-range>573-81</page-range>
            <pub-id pub-id-type="pmid">25047029</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20509.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Johung</surname>
                <given-names>TB</given-names>
              </name>
              <name>
                <surname>Monje</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Diffuse Intrinsic Pontine Glioma: New Pathophysiological Insights and Emerging Therapeutic Targets.</article-title>
            <source>Curr Neuropharmacol</source>
            <year>2017</year>
            <volume>15</volume>
            <issue>1</issue>
            <fpage>88</fpage>
            <page-range>88-97</page-range>
            <pub-id pub-id-type="pmid">27157264</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20509.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schroeder</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Hoeman</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Becher</surname>
                <given-names>OJ</given-names>
              </name>
            </person-group>
            <article-title>Children are not just little adults: recent advances in understanding of diffuse intrinsic pontine glioma biology.</article-title>
            <source>Pediatr Res</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>75</volume>
            <issue>1-2</issue>
            <fpage>205</fpage>
            <page-range>205-9</page-range>
            <pub-id pub-id-type="pmid">24192697</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20509.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lober</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Barnes</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Edwards</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Vogel</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Fisher</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Monje</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yeom</surname>
                <given-names>KW</given-names>
              </name>
            </person-group>
            <article-title>Diffusion-weighted MRI derived apparent diffusion coefficient identifies prognostically distinct subgroups of pediatric diffuse intrinsic pontine glioma.</article-title>
            <source>J Neurooncol</source>
            <year>2014</year>
            <month>Mar</month>
            <volume>117</volume>
            <issue>1</issue>
            <fpage>175</fpage>
            <page-range>175-82</page-range>
            <pub-id pub-id-type="pmid">24522717</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20509.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leach</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Roebker</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Schafer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Baugh</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chaney</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Fuller</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Fouladi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lane</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Doughman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Drissi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>DeWire-Schottmiller</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ziegler</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Minturn</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Hansford</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Monje-Deisseroth</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fisher</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Gottardo</surname>
                <given-names>NG</given-names>
              </name>
              <name>
                <surname>Dholaria</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Packer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Warren</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Leary</surname>
                <given-names>SES</given-names>
              </name>
              <name>
                <surname>Goldman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bartels</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Hawkins</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>BV</given-names>
              </name>
            </person-group>
            <article-title>MR imaging features of diffuse intrinsic pontine glioma and relationship to overall survival: report from the International DIPG Registry.</article-title>
            <source>Neuro Oncol</source>
            <year>2020</year>
            <month>Nov</month>
            <day>26</day>
            <volume>22</volume>
            <issue>11</issue>
            <fpage>1647</fpage>
            <page-range>1647-1657</page-range>
            <pub-id pub-id-type="pmid">32506137</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20509.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vitanza</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Monje</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Diffuse Intrinsic Pontine Glioma: From Diagnosis to Next-Generation Clinical Trials.</article-title>
            <source>Curr Treat Options Neurol</source>
            <year>2019</year>
            <month>Jul</month>
            <day>10</day>
            <volume>21</volume>
            <issue>8</issue>
            <fpage>37</fpage>
            <pub-id pub-id-type="pmid">31290035</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20509.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huang</surname>
                <given-names>TY</given-names>
              </name>
              <name>
                <surname>Piunti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lulla</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Qi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Horbinski</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Tomita</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>James</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Shilatifard</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Saratsis</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma.</article-title>
            <source>Acta Neuropathol Commun</source>
            <year>2017</year>
            <month>Apr</month>
            <day>17</day>
            <volume>5</volume>
            <issue>1</issue>
            <fpage>28</fpage>
            <pub-id pub-id-type="pmid">28416018</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20509.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saratsis</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Yadavilli</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Magge</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rood</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Perez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Hwang</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kilburn</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Packer</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Nazarian</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Insights into pediatric diffuse intrinsic pontine glioma through proteomic analysis of cerebrospinal fluid.</article-title>
            <source>Neuro Oncol</source>
            <year>2012</year>
            <month>May</month>
            <volume>14</volume>
            <issue>5</issue>
            <fpage>547</fpage>
            <page-range>547-60</page-range>
            <pub-id pub-id-type="pmid">22492959</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20509.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pan</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Diplas</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Xiao</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Geng</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jiao</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yan</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Molecular profiling of tumors of the brainstem by sequencing of CSF-derived circulating tumor DNA.</article-title>
            <source>Acta Neuropathol</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>137</volume>
            <issue>2</issue>
            <fpage>297</fpage>
            <page-range>297-306</page-range>
            <pub-id pub-id-type="pmid">30460397</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20509.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Coutinho</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Chapman</surname>
                <given-names>KE</given-names>
              </name>
            </person-group>
            <article-title>The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights.</article-title>
            <source>Mol Cell Endocrinol</source>
            <year>2011</year>
            <month>Mar</month>
            <day>15</day>
            <volume>335</volume>
            <issue>1</issue>
            <fpage>2</fpage>
            <page-range>2-13</page-range>
            <pub-id pub-id-type="pmid">20398732</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20509.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pappachan</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Hariman</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Edavalath</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Waldron</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hanna</surname>
                <given-names>FW</given-names>
              </name>
            </person-group>
            <article-title>Cushing's syndrome: a practical approach to diagnosis and differential diagnoses.</article-title>
            <source>J Clin Pathol</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>70</volume>
            <issue>4</issue>
            <fpage>350</fpage>
            <page-range>350-359</page-range>
            <pub-id pub-id-type="pmid">28069628</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20509.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hue</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>FS</given-names>
              </name>
              <name>
                <surname>Cao</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dale Bass</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Meaney</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Morrison</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Dexamethasone potentiates in vitro blood-brain barrier recovery after primary blast injury by glucocorticoid receptor-mediated upregulation of ZO-1 tight junction protein.</article-title>
            <source>J Cereb Blood Flow Metab</source>
            <year>2015</year>
            <month>Jul</month>
            <volume>35</volume>
            <issue>7</issue>
            <fpage>1191</fpage>
            <page-range>1191-8</page-range>
            <pub-id pub-id-type="pmid">25757751</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20509.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Luedi</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Mosley</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Hatami</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gumin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sulman</surname>
                <given-names>EP</given-names>
              </name>
              <name>
                <surname>Lang</surname>
                <given-names>FF</given-names>
              </name>
              <name>
                <surname>Stueber</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Zinn</surname>
                <given-names>PO</given-names>
              </name>
              <name>
                <surname>Colen</surname>
                <given-names>RR</given-names>
              </name>
            </person-group>
            <article-title>A Dexamethasone-regulated Gene Signature Is Prognostic for Poor Survival in Glioblastoma Patients.</article-title>
            <source>J Neurosurg Anesthesiol</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>29</volume>
            <issue>1</issue>
            <fpage>46</fpage>
            <page-range>46-58</page-range>
            <pub-id pub-id-type="pmid">27653222</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20509.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guida</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Roux</surname>
                <given-names>FE</given-names>
              </name>
              <name>
                <surname>Massimino</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Marras</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Sganzerla</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Giussani</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Safety and efficacy of Endoscopic Third Ventriculostomy in Diffuse Intrinsic Pontine Glioma related hydrocephalus: a Systematic Review.</article-title>
            <source>World Neurosurg</source>
            <year>2018</year>
            <month>Dec</month>
            <day>29</day>
            <pub-id pub-id-type="pmid">30599251</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20509.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Puget</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Beccaria</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Blauwblomme</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Roujeau</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>James</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Grill</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zerah</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Varlet</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sainte-Rose</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Biopsy in a series of 130 pediatric diffuse intrinsic Pontine gliomas.</article-title>
            <source>Childs Nerv Syst</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>31</volume>
            <issue>10</issue>
            <fpage>1773</fpage>
            <page-range>1773-80</page-range>
            <pub-id pub-id-type="pmid">26351229</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20509.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kieran</surname>
                <given-names>MW</given-names>
              </name>
            </person-group>
            <article-title>Time to rethink the unthinkable: upfront biopsy of children with newly diagnosed diffuse intrinsic pontine glioma (DIPG).</article-title>
            <source>Pediatr Blood Cancer</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>62</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <page-range>3-4</page-range>
            <pub-id pub-id-type="pmid">25284709</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20509.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carai</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mastronuzzi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>De Benedictis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Messina</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cacchione</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Miele</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Randi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Esposito</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Trezza</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Colafati</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Savioli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Locatelli</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Marras</surname>
                <given-names>CE</given-names>
              </name>
            </person-group>
            <article-title>Robot-Assisted Stereotactic Biopsy of Diffuse Intrinsic Pontine Glioma: A Single-Center Experience.</article-title>
            <source>World Neurosurg</source>
            <year>2017</year>
            <month>May</month>
            <volume>101</volume>
            <fpage>584</fpage>
            <page-range>584-588</page-range>
            <pub-id pub-id-type="pmid">28254596</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20509.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gallitto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lazarev</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wasserman</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Stafford</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Wolden</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Terezakis</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Bindra</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Bakst</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>Role of Radiation Therapy in the Management of Diffuse Intrinsic Pontine Glioma: A Systematic Review.</article-title>
            <source>Adv Radiat Oncol</source>
            <year>2019</year>
            <season>Jul-Sep</season>
            <volume>4</volume>
            <issue>3</issue>
            <fpage>520</fpage>
            <page-range>520-531</page-range>
            <pub-id pub-id-type="pmid">31360809</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20509.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Janssens</surname>
                <given-names>GO</given-names>
              </name>
              <name>
                <surname>Jansen</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Lauwers</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Nowak</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Oldenburger</surname>
                <given-names>FR</given-names>
              </name>
              <name>
                <surname>Bouffet</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Saran</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Kamphuis-van Ulzen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>van Lindert</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Schieving</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Boterberg</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kaspers</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Span</surname>
                <given-names>PN</given-names>
              </name>
              <name>
                <surname>Kaanders</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Gidding</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Hargrave</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Hypofractionation vs conventional radiation therapy for newly diagnosed diffuse intrinsic pontine glioma: a matched-cohort analysis.</article-title>
            <source>Int J Radiat Oncol Biol Phys</source>
            <year>2013</year>
            <month>Feb</month>
            <day>01</day>
            <volume>85</volume>
            <issue>2</issue>
            <fpage>315</fpage>
            <page-range>315-20</page-range>
            <pub-id pub-id-type="pmid">22682807</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20509.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zaghloul</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Eldebawy</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ahmed</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mousa</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Amin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Refaat</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zaky</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Elkhateeb</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sabry</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial.</article-title>
            <source>Radiother Oncol</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>111</volume>
            <issue>1</issue>
            <fpage>35</fpage>
            <page-range>35-40</page-range>
            <pub-id pub-id-type="pmid">24560760</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20509.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Freese</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Takiar</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Fouladi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>DeWire</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Breneman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pater</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Radiation and subsequent reirradiation outcomes in the treatment of diffuse intrinsic pontine glioma and a systematic review of the reirradiation literature.</article-title>
            <source>Pract Radiat Oncol</source>
            <year>2017</year>
            <season>Mar-Apr</season>
            <volume>7</volume>
            <issue>2</issue>
            <fpage>86</fpage>
            <page-range>86-92</page-range>
            <pub-id pub-id-type="pmid">28274399</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20509.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lassaletta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Strother</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Laperriere</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hukin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Vanan</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Goddard</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lafay-Cousin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Johnston</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Zelcer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zapotocky</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rajagopal</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ramaswamy</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Hawkins</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tabori</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bartels</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Bouffet</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Reirradiation in patients with diffuse intrinsic pontine gliomas: The Canadian experience.</article-title>
            <source>Pediatr Blood Cancer</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>65</volume>
            <issue>6</issue>
            <fpage>e26988</fpage>
            <pub-id pub-id-type="pmid">29369515</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20509.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rechberger</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>VM</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Power</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Daniels</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Clinical trials for diffuse intrinsic pontine glioma: the current state of affairs.</article-title>
            <source>Childs Nerv Syst</source>
            <year>2020</year>
            <month>Jan</month>
            <volume>36</volume>
            <issue>1</issue>
            <fpage>39</fpage>
            <page-range>39-46</page-range>
            <pub-id pub-id-type="pmid">31489454</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20509.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Janjua</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Ban</surname>
                <given-names>VS</given-names>
              </name>
              <name>
                <surname>El Ahmadieh</surname>
                <given-names>TY</given-names>
              </name>
              <name>
                <surname>Hwang</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Samdani</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Price</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>Weprin</surname>
                <given-names>BE</given-names>
              </name>
              <name>
                <surname>Batjer</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Diffuse intrinsic pontine gliomas: Diagnostic approach and treatment strategies.</article-title>
            <source>J Clin Neurosci</source>
            <year>2020</year>
            <month>Feb</month>
            <volume>72</volume>
            <fpage>15</fpage>
            <page-range>15-19</page-range>
            <pub-id pub-id-type="pmid">31870682</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20509.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Van Gool</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Makalowski</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bonner</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Feyen</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Domogalla</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Prix</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Schirrmacher</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Nazarian</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Stuecker</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Addition of Multimodal Immunotherapy to Combination Treatment Strategies for Children with DIPG: A Single Institution Experience.</article-title>
            <source>Medicines (Basel)</source>
            <year>2020</year>
            <month>May</month>
            <day>19</day>
            <volume>7</volume>
            <issue>5</issue>
            <pub-id pub-id-type="pmid">32438648</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20509.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rashed</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Maher</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Adel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Saber</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Zaghloul</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Pediatric diffuse intrinsic pontine glioma: where do we stand?</article-title>
            <source>Cancer Metastasis Rev</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>38</volume>
            <issue>4</issue>
            <fpage>759</fpage>
            <page-range>759-770</page-range>
            <pub-id pub-id-type="pmid">31802357</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20509.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mandrell</surname>
                <given-names>BN</given-names>
              </name>
              <name>
                <surname>Baker</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Levine</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gattuso</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>West</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sykes</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gajjar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Broniscer</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Children with minimal chance for cure: parent proxy of the child's health-related quality of life and the effect on parental physical and mental health during treatment.</article-title>
            <source>J Neurooncol</source>
            <year>2016</year>
            <month>Sep</month>
            <volume>129</volume>
            <issue>2</issue>
            <fpage>373</fpage>
            <page-range>373-81</page-range>
            <pub-id pub-id-type="pmid">27344555</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
